Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  28 (2024)
Volume  27 (2023)
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Volume  18 (2014)
Volume  17 (2013)
Volume  16 (2012)
Volume  15 (2011)
Volume  14 (2010)
Volume  13 (2009)
Volume  12 (2008)
Volume  11 (2007)
Volume  10 (2006)
Volume  9 (2005)
Volume  8 (2004)
Related articles

VOLUME 28 , ISSUE 10 ( October, 2024 ) > List of Articles

EDITORIAL

Polymyxin B Hemoperfusion in Sepsis: A Possible Silver Lining to the Dark Clouds?

Jeetendra Sharma, Shivangi K Khatav

Keywords : Hemoperfusion, Mortality, Polymyxin B, Sepsis, Septic shock

Citation Information : Sharma J, Khatav SK. Polymyxin B Hemoperfusion in Sepsis: A Possible Silver Lining to the Dark Clouds?. Indian J Crit Care Med 2024; 28 (10):903-905.

DOI: 10.5005/jp-journals-10071-24816

License: CC BY-NC 4.0

Published Online: 30-09-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract
PDF Share
  1. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: Analysis for the Global Burden of Disease Study. Lancet 2020;395(10219):200–211. DOI: 10.1016/S0140-6736(19)32989-7.
  2. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016;315(8):801–810. DOI: 10.1001/jama.2016.0287.
  3. Ghosh S, Latimer RD, Gray BM, Harwood RJ, Oduro A. Endotoxin-induced organ injury. Crit Care Med 1993;21(2 Suppl):S19–S24. DOI: 10.1097/00003246-199302001-00005.
  4. Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, et al. Diagnostic and prognostic implications of endotoxemia in critical illness: Results of the MEDIC study. J Infect Dis 2004;190(3):527–534. DOI: 10.1086/422254.
  5. Rimmele T, Kellum JA. Clinical review: Blood purification for sepsis. Crit Care 2011;15(1):205. DOI: 10.1186/cc9411.
  6. Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: The peak concentration hypothesis. Artif Organs 2003;27(9):792–801. DOI: 10.1046/j.1525-1594.2003.07289.
  7. Srisawat N, Tungsanga S, Lumlertgul N, Komaenthammasophon C, Peerapornratana S, Thamrongsat N, et al. The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients. Crit Care 2018;22(1):279. DOI: 10.1186/s13054-018-2077.
  8. Clark E, Molnar AO, Joannes-Boyau O, Honoré PM, Sikora L, Bagshaw SM. High-volume hemofiltration for septic acute kidney injury: A systematic review and meta-analysis. Crit Care 2014;18(1):R7. DOI: 10.1186/cc13184.
  9. Atan R, Peck L, Prowle J, Licari E, Eastwood GM, Storr M, et al. A double-blind randomized controlled trial of high cutoff versus standard hemofiltration in critically Ill patients with acute kidney injury. Crit Care Med 2018;46(10):e988–e994. DOI: 10.1097/CCM.0000000000003350.
  10. Livigni S, Bertolini G, Rossi C, Ferrari F, Giardino M, Pozzato M, et al. Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: A multicenter randomised controlled clinical trial. BMJ Open 2014;4(1):e003536. DOI: 10.1136/bmjopen-2013-003536.
  11. Schadler D, Pausch C, Heise D, Meier-Hellmann A, Brederlau J, Weiler N, et al. The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial. PLoS One 2017;12(10):e0187015. DOI: 10.1371/journal.pone.0187015.
  12. Pickkers P, Vassiliou T, Liguts V, Prato F, Tissieres P, Kloesel S, et al. Sepsis management with a blood purification membrane: European experience. Blood Purif 2019;47(Suppl 3):1–9. DOI: 10.1159/0004 99355.
  13. Vesentini S, Soncini M, Zaupa A, Silvestri V, Fiore GB, Redaelli A. Multi-scale analysis of the toraymyxin adsorption cartridge. Part I: Molecular interaction of polymyxin B with endotoxins. Int J Artif Organs 2006;29(2):239–250. DOI: 10.1177/039139880602900210.
  14. Nishibori M, Takahashi HK, Katayama H, Mori S, Saito S, Iwagaki H, et al. Specific removal of monocytes from peripheral blood of septic patients by polymyxin B-immobilized filter column. Acta Med Okayama 2009;63(1):65–69. DOI: 10.18926/AMO/31855.
  15. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, et al. Early use of Polymyxin B hemoperfusion in abdominal septic shock: The EUPHAS randomized controlled trial. J Am Med Assoc 2009;301(23):2445–2452. DOI: 10.1001/jama.2009.856.
  16. Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, et al. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: A multicenter randomized control trial. Intensive Care Med 2015;41(6):975–984. DOI: 10.1007/s00134-015-3751.
  17. Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, et al. Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: The EUPHRATES randomized clinical trial. J Am Med Assoc 2018;320(14):1455–1463. DOI: 10.1001/jama.2018. 14618.
  18. Klein DJ, Foster D, Walker PM, Bagshaw SM, Mekonnen H, Antonelli M. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: A post hoc analysis of the EUPHRATES trial. Intensive Care Med 2018;44(12):2205–2212. DOI: 10.1007/s00134-018-5463-7.
  19. Nakamura Y, Kitamura T, Kiyomi F, Hayakawa M, Hoshino K, Kawano Y, et al. Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: A propensity-matched cohort study. Crit Care 2017;21(1):134. DOI: 10.1186/s13054-017-1712-3.
  20. Ghosh I, Sangha S, Pandey G, Srivastava A. Efficacy of polymyxin B hemoperfusion for treatment of sepsis. Indian J Crit Care Med 2024;28(10):930–934.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.